Role of Biomarkers in the Management of Acute Myeloid Leukemia

Despite many recent advances in treatment options, acute myeloid leukemia (AML) still has a high mortality rate. One important issue in optimizing outcomes for AML patients lies in the limited ability to predict response to specific therapies, duration of response, and likelihood of relapse. With ev...

Descripción completa

Detalles Bibliográficos
Autores principales: Small, Sara, Oh, Timothy S., Platanias, Leonidas C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9741257/
https://www.ncbi.nlm.nih.gov/pubmed/36498870
http://dx.doi.org/10.3390/ijms232314543

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9741257/
https://www.ncbi.nlm.nih.gov/pubmed/36498870
http://dx.doi.org/10.3390/ijms232314543

Ejemplares similares